Concepedia

Yared Hailemichael

YH

Statistics

Publications

25

Citations

2.6K

H-Index

23

Active since

2009

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Houston

Melanoma Institute Australia

The University of Texas Health Science Center at Houston

Icahn School of Medicine at Mount Sinai

Yared Hailemichael is an author at The University of Texas MD Anderson Cancer Center specializing in cancer immunotherapy, immunology, and oncology.

ORCID

Publications per year

2009–2022

25

Publications

25

Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion

Yared Hailemichael, Zhimin Dai, Nina Jaffarzad et al. · Nature Medicine · 2013 · 450 citations

, , +16

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Yared Hailemichael, Daniel H. Johnson, Noha Abdel‐Wahab et al. · Cancer Cell · 2022 · 344 citations · Full text

, , +14

Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice

Hong Qin, Beatrisa Lerman, Ippei Sakamaki et al. · Nature Medicine · 2014 · 235 citations · Full text

, , +15

Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy

Meenu Sharma, Hiep Khong, Faisal Fa’ak et al. · Nature Communications · 2020 · 169 citations · Full text

, , +17

The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies

Sruthy Varghese, Snigdha Pramanik, Leila J. Williams et al. · Molecular Cancer Therapeutics · 2020 · 163 citations · Full text

, , +17

1–5 of 25